Navigation Links
Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge
Date:8/19/2008

Amsterdam, August 19, 2008 -- Elsevier, a leading global healthcare and scientific publisher, has announced ten semi-finalists in The Elsevier Grand Challenge, a competition inviting the scientific community to prototype tools innovating how Life Sciences information is used in online text databases. The ten semifinalists were chosen by a distinguished panel of judges from among over 70 excellent entries offering a range of approaches involving semantics, visualization, protocols, social networks, and citations. The semifinalists include:

  • Sean O'Donoghue and Lars Jensen, Germany, for "Reflect: Automated Annotation of Scientific Terms"

  • Timothy Baldwin, Lawrence Cavedon, Sarvnaz Karimi, David Martinez, David Newman, Falk Scholer and Justin Zobel, Australia and US, "Effective Search, Classification, and Visualisation of Information from Large Collections of Biomedical Literature"

  • Vit Novacek, Siegfried Handschuh and Tudor Groza, Ireland, "Teaching Machines to Teach Us: A Truly Knowledge-Based Publication Management"

  • Amr Ahmed, Andrew Arnold, Luis Pedro Coelho, Saboor Sheikh, Eric Xing, William Cohen and Robert F. Murphy, US, "Information Retrieval and Topic Discovery using both Figures and Captions in Biological Literature"

  • Stephen Wan, Robert Dale and Cecile Paris, Australia, "In-Context Summaries of Cited Documents: A Research Prototype for Academic and Scholarly Literature"

  • Roderic Page, UK, "Towards realising Darwin's dream: setting the trees free"

  • Jose Gonzalez-Brenes, Aabid Shariff, Sourish Chaudhuri and Carolyn Rose, US, "Automating the Generation of Life Science Protocols"

  • Glenn Ford, Sameer Antani, Dina Demner Fushman and George Thoma, US, "Tools to build and use Interactive Publications"


  • '/>"/>

Contact: Noelle Gracy
n.gracy@elsevier.com
31-204-853-029
Elsevier
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Elsevier launches Bioscience Hypotheses
2. Elsevier launches new journal: Journal of Natural Gas Science and Engineering
3. Elsevier announces new journal partnership for 2008
4. Institution of Chemical Engineers chooses Elsevier as publishing partner
5. Cuellars Safe and Lock Announces Strategic Alliance with Absolute Access and Security
6. JDRF announces 2008 Scholar Award recipients
7. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
8. Ecological Society of America announces 2008 award recipients
9. Aware Announces Q2 2008 Earnings Conference Call
10. US Department of Energy Joint Genome Institute announces new genome sequencing projects
11. NIAID announces grants to stimulate food allergy research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... strength, but it also holds the promise of a ... to convert sunlight into a clean, efficient alternative fuel. ... group using spinach to study the proteins involved in ... energy into carbohydrates used to power cellular processes. , ... efficient system ever built, capable of converting the energy ...
(Date:7/23/2014)... Migratory songbirds are disappearing, and though conservationists are examining ... habitat, acid rain and light pollution, a key piece ... birds go once they leave their breeding sites, and ... , To answer this question, a team of researchers ... migratory connectivity map produced for a songbird, using tracking ...
(Date:7/23/2014)... planet,s soil releases about 60 billion tons of carbon ... than that released by burning fossil fuels. This happens ... of carbon is balanced by carbon coming into the ... as well as by the underground activities of plant ... rising temperatures increase the rate of soil respiration. As ...
Breaking Biology News(10 mins):Spinach could lead to alternative energy more powerful than Popeye 2York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2Climate change and the soil 2
... 2012) Aeras and the Infectious Disease Research Institute ... trial of IDRI,s novel tuberculosis vaccine candidate, ID93 + ... safety, tolerability and immunogenicity of the vaccine candidate in ... by Johnson County Clin-Trials in Lenexa, Kansas, in close ...
... has on pregnancy, are urging men to get ... development. Reproductive experts from the University of ... father,s obesity negatively impacts sperm, resulting in smaller ... While the health risks surrounding obesity ...
... Venture has developed a framework to evaluate the risk ... A paper based on this work: A framework for ... has been published in the Malaria Journal ... anti-infective drug, so it is important when developing new ...
Cached Biology News:As TB grows more difficult to control, vaccine candidate to prevent disease enters clinical testing 2Thinking about kids? Man, you gotta shed the kilos 2MMV develops framework to assess risk of resistance for antimalarial compounds 2
(Date:7/23/2014)... LOS ANGELES , July 23, 2014 /PRNewswire-iReach/ -- ... enhance cognitive performance for the long term. They are ... competitive edge of sustained energy as an alternative to ... launch Think Drinks on Indiegogo on July 29, 2014, ... the 30-day campaign. Photo - http://photos.prnewswire.com/prnh/20140723/129697 ...
(Date:7/23/2014)... Last year, Formedix celebrated its ... provider of data management solutions for clinical trials. The ... for electronic data capture (EDC) and clinical data management. ... execution tools added TrialMaster to its Transform for EDC ... Transform for TrialMaster, is being released this week, in ...
(Date:7/23/2014)... July 23, 2014 StemGenex® , ... in the US aimed at improving the lives of ... clinical study for Parkinson’s disease. StemGenex believes that ... cell therapy are paramount when providing care to patients ... makes stem cell therapy accessible to the millions of ...
(Date:7/23/2014)... - BioAmber Inc. (NYSE: BIOA ), ... that the underwriters of its common stock offering ... additional 420,000 shares of common stock at the ... underwriting discounts and commissions, in connection with its ... of common stock, bringing the expected net proceeds ...
Breaking Biology Technology:truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3
... Calif., March 20, 2012 Cepheid (NASDAQ: ... of Medicine and Dentistry of New Jersey (UMDNJ), it ... Health to develop sample processing and amplification methods for ... reaction (PCR) on the GeneXpert® System. The $1.3 million ...
... March 20, 2012 Heptares Therapeutics, the ... company of Shire PLC (LSE: SHP, NASDAQ: ... its exclusive option to license a novel adenosine A ... in preclinical development. Adenosine A 2A is a ...
... 19, 2012  MiMedx Group, Inc. (OTCBB: MDXG), an ... regenerative biomaterials and bioimplants processed from human amniotic ... distribution agreement with Systagenix, whereby Systagenix will co-market ... specifically processed from amniotic tissue, EpiFix® offers a ...
Cached Biology Technology:Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 2Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 3Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 4Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders 2Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders 3MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 2MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 3